People may learn they have a gene mutation linked to some types of cardiovascular disease (CVD) as the usage of genetic testing rises. In order to better inform people and medical professionals on what to do when a variant is found.
Using technology created by a researcher at UTHealth Houston, a new study shows that the presence of a misfolded alpha-synuclein protein can be used to identify persons with Parkinson's disease. The discovery of this biomarker may lead to the creation of more accurate diagnostic equipment an
Understanding how cancer develops is necessary for designing efficient, individualised cancer medicines. Scientists have known for many years that certain types of gene mutations are the cause of cancer.
Designing efficient, individualised cancer medicines requires an understanding of how cancer develops. For many years, scientists have understood that certain kinds of gene mutations are the origin of cancer.
A study has shown the biological foundations of a reproductive problem brought on by a gene mutation. Fragile X Syndrome, a major hereditary cause of intellectual disability and autism, is also brought on by this gene mutation.
Gene mutations are the cause of cancer. Tumor suppressors and oncogenes are the two main groups of these altered genes in cancer. Mutations in oncogenes can drive cell proliferation, pushing the gas pedal all the way to the floor, whereas mutations in tumour suppressor genes can cause tumour
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif
Glioblastoma is the most lethal and malignant adult brain cancer that may arise from the neuroglial stem or progenitor cells. Certain gene mutations or those with a known history of other cancers and radiation therapy may predispose patients to develop brain cancer. Tumour relapse is invaria
Cancer-causing gene mutation KRAS, found in nearly 30 per cent of all human tumours, successfully shrunk tumours or stopped cancer growth in preclinical models of pancreatic cancer.
Researchers have long searched for genetic influences in schizophrenia, a neurodevelopmental disorder that disrupts brain activity producing hallucinations, delusions, and other cognitive disturbances. However, the disease's genetic mutations have been identified in only a small fraction few